ASX - Delayed Quote AUD

Orthocell Limited (OCC.AX)

0.3750 -0.0050 (-1.32%)
At close: April 26 at 3:52 PM GMT+10
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
4,243.0690
4,243.0690
1,531.7180
1,017.9620
719.5230
Cost of Revenue
1,026.1550
1,026.1550
702.6100
625.6450
505.3740
Gross Profit
3,216.9140
3,216.9140
829.1080
392.3170
214.1490
Operating Expense
14,111.5870
14,111.5870
12,702.3340
12,497.2640
9,729.5620
Operating Income
-10,894.6730
-10,894.6730
-11,873.2260
-12,104.9470
-9,515.4130
Net Non Operating Interest Income Expense
850.7930
850.7930
84.1290
199.2420
116.3850
Other Income Expense
79.1980
79.1980
189.9380
38.6310
82.9400
Pretax Income
-9,410.5610
-9,410.5610
-11,250.5400
-11,431.4220
-9,055.5750
Tax Provision
-3,162.3800
-3,162.3800
-2,143.9550
-2,394.3970
-2,904.5460
Net Income Common Stockholders
-6,248.1810
-6,248.1810
-9,106.5850
-9,037.0250
-6,151.0290
Basic EPS
-0.03
-0.03
-0.05
-0.05
-0.04
Diluted EPS
-0.03
-0.03
-0.05
-0.05
-0.04
Basic Average Shares
197,213.3930
197,213.3930
194,665.8340
186,852.6700
171,003.3750
Diluted Average Shares
197,213.3930
197,213.3930
194,665.8340
186,852.6700
171,003.3750
Net Income from Continuing & Discontinued Operation
-6,248.1810
-6,248.1810
-9,106.5850
-9,037.0250
-6,151.0290
Normalized Income
-6,248.1810
-6,248.1810
-9,106.5850
-9,037.0250
-6,151.0290
Interest Income
850.7930
850.7930
84.1290
199.2420
116.3850
Net Interest Income
850.7930
850.7930
84.1290
199.2420
116.3850
EBIT
-10,894.6730
-10,894.6730
-11,873.2260
-12,104.9470
-9,515.4130
EBITDA
-10,340.5520
-10,340.5520
-11,524.6070
-11,669.2950
-9,254.9000
Reconciled Cost of Revenue
1,026.1550
1,026.1550
702.6100
625.6450
505.3740
Reconciled Depreciation
554.1210
554.1210
348.6190
435.6520
260.5130
Net Income from Continuing Operation Net Minority Interest
-6,248.1810
-6,248.1810
-9,106.5850
-9,037.0250
-6,151.0290
Normalized EBITDA
-10,340.5520
-10,340.5520
-11,524.6070
-11,669.2950
-9,254.9000
Tax Rate for Calcs
0.0003
0.0003
0.0002
0.0002
0.0003
6/30/2020 - 8/12/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TRP.AX Tissue Repair Ltd
0.2300
0.00%
 
HXL.AX Hexima Limited
0.0130
0.00%
 
PAB.AX Patrys Limited
0.0090
0.00%
 
PYC.AX PYC Therapeutics Limited
0.0920
-1.08%
 
MEM.AX Memphasys Limited
0.0080
0.00%
 
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0480
-7.69%
 
VBS.AX Vectus Biosystems Limited
0.2750
0.00%
 
NYR.AX Nyrada Inc.
0.0940
-2.08%
 
SPL.AX Starpharma Holdings Limited
0.1350
0.00%
 
IXC.AX Invex Therapeutics Ltd
0.0800
-2.44%